Medical News

RSS

Report prompts close scrutiny of charity care at Calif. nonprofit hospitals

Nonprofit California hospitals will face a state Senate committee hearing Wednesday after an auditor's report found variance and leeway in just how much charity care the tax-exempt hospitals give.

16 Aug 2012

Human milk oligosaccharides may reduce risk of mother-to-child HIV transmission

An international team of researchers has found that certain bioactive components found in human milk are associated with a reduced risk of HIV transmission from an HIV infected mother to her breast-fed infant. Their study will be published in the August 15 online edition of American Journal of Clinical Nutrition.

16 Aug 2012

'Impatient Optimists' blog posts examines 'Reinvent the Toilet Fair' in Seattle

In this post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, co-chair Bill Gates discusses the foundation's Reinvent the Toilet Fair, held this week in Seattle, which "brought together about 200 grantees, partners, and others who are passionate about creating safe, effective, and inexpensive sanitation services for people without access to flush toilets."

16 Aug 2012

Enzalutamide drug can extend life and improve QOL in men with advanced prostate cancer

The head of one of the UK's leading cancer research organisations has hailed a golden age in prostate cancer drug discovery as for the fourth time in two years results are published finding a new drug can significantly extend life.

16 Aug 2012

It's not just Medicare: Ryan's Medicaid proposals emerge as campaign issue

News outlets report that the changes to Medicaid proposed by likely GOP vice presidential nominee Rep. Paul Ryan would have immediate and far-reaching consequences for millions of people, including poor seniors.

16 Aug 2012

Passenger deletions that deactivate essential genes provide new opportunity to strike cancer

Genomic deletions promote cancer by carving up or eliminating tumor-suppressor genes, but now scientists report in the journal Nature that the collateral damage they inflict on neighboring genes exposes cancer cells to vulnerabilities and new avenues for attack.

16 Aug 2012

Scientists researching Ebola virus say vaccine 'unlikely' due to funding restraints

"Scientists researching the lethal Ebola virus have told [BBC News] that a commercial vaccine to prevent the onset of infection may never be developed," the news service reports.

16 Aug 2012

APS’ Sharon S. Keller Chronic Pain Research Program to award $150,000 for eligible members

The American Pain Society (APS) announced today it is accepting applications for research grants from the newly established Sharon S. Keller Chronic Pain Research Program.

16 Aug 2012

India launches new laboratory for HIV vaccine research in collaboration with IAVI

India on Monday "opened a $12 million, government-backed laboratory whose mission is to create a new vaccine against HIV," Science Insider reports.

16 Aug 2012

Malignant mesothelioma diagnosis with an E-nose: an interview with Associate Professor Deborah Yates, UNSW

Malignant mesothelioma is a rare tumor of the pleura which is the lining of the inside of the chest wall. It is highly linked with asbestos exposure.

16 Aug 2012

Book provides up-to-date knowledge about mild cognitive impairment

At least one in ten adults over the age of 65 suffers from Mild Cognitive Impairment, or MCI. This condition, a state between the normal decline in cognition associated with aging and the more precipitous drop caused by a deadly dementia like Alzheimer's disease, has only recently begun to be studied; first identified by the Mayo Clinic in 1999, it was only given an official diagnostic code in late 2006.

16 Aug 2012

Ohio Medicaid readies new nursing home reimbursement; New nursing home database launched

Ohio's nursing home program in Medicaid -- the federal-state health care program for the poor -- is changing how nursing homes are paid to try to address their quality. In the meantime, ProPublica launches a nursing home inspection database.

16 Aug 2012

Medicago, IDRI receive FDA approval to commence Phase 1 H5N1 vaccine trial

The Infectious Disease Research Institute (IDRI), a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), announce that they have been cleared by the U.S. Food and Drug Administration (FDA) to initiate a Phase 1 clinical trial for an H5N1 Avian Influenza VLP vaccine candidate.

16 Aug 2012

Low adropin levels may increase risk of metabolic disease

Working with a national team of researchers, a scientist from the Florida campus of The Scripps Research Institute has shown for the first time a link between low levels of a specific hormone and increased risk of metabolic disease in humans.

16 Aug 2012

Physical activity effective in reducing sclerostin in premenopausal women

A study to be published in the Endocrine Society's Journal of Clinical Endocrinology and Metabolism (JCEM) suggests that physical activity for premenopausal women is very effective in reducing sclerostin-a known inhibitor of bone formation. In addition, physical training enhances IGF-1levels, which have a very positive effect on bone formation.

16 Aug 2012

Special device provides evidence of how bloodstream infections begin

New research may help explain why hundreds of thousands of Americans a year get sick - and tens of thousands die - after bacteria get into their blood. It also suggests why some of those bloodstream infections resist treatment with even the most powerful antibiotics.

16 Aug 2012

Continuous oral contraceptives provide earlier relief for women with dysmenorrhea

Taking oral contraceptives continuously, rather than as traditionally prescribed for each cycle, provides earlier relief for moderate to severe menstrual cramps -- dysmenorrhea -- according to researchers at Penn State College of Medicine.

16 Aug 2012

Article describes novel technique to study interactions between HIV-1 and P. falciparum

The World Health Organization estimates that in 2011 there were 216 million cases of malaria and 34.2 million people living with HIV. These diseases particularly afflict sub-Saharan Africa, where large incidence of co-infection result in high mortality rates. Yet, in spite of this global pandemic, interactions between the parasite that causes malaria, Plasmodium falciparum, and HIV-1 are poorly understood.

16 Aug 2012

RNA-delivering nanoparticles allow rapid screening of new drug targets in mice

By sequencing cancer-cell genomes, scientists have discovered vast numbers of genes that are mutated, deleted or copied in cancer cells. This treasure trove is a boon for researchers seeking new drug targets, but it is nearly impossible to test them all in a timely fashion.

16 Aug 2012

Inhibiting over-production of Panx1 protein can treat melanoma

New research from Western University, Canada, has identified a potential new target for the treatment of melanoma, the deadliest of all skin cancers. Silvia Penuela and Dale Laird discovered a new channel-forming protein called Pannexin (Panx1) that is expressed in normal levels on the surface of healthy skin cells.

16 Aug 2012

Medical News

Report prompts close scrutiny of charity care at Calif. nonprofit hospitals

Human milk oligosaccharides may reduce risk of mother-to-child HIV transmission

'Impatient Optimists' blog posts examines 'Reinvent the Toilet Fair' in Seattle

Enzalutamide drug can extend life and improve QOL in men with advanced prostate cancer

It's not just Medicare: Ryan's Medicaid proposals emerge as campaign issue

Passenger deletions that deactivate essential genes provide new opportunity to strike cancer

Scientists researching Ebola virus say vaccine 'unlikely' due to funding restraints

APS’ Sharon S. Keller Chronic Pain Research Program to award $150,000 for eligible members

India launches new laboratory for HIV vaccine research in collaboration with IAVI

Malignant mesothelioma diagnosis with an E-nose: an interview with Associate Professor Deborah Yates, UNSW

Book provides up-to-date knowledge about mild cognitive impairment

Ohio Medicaid readies new nursing home reimbursement; New nursing home database launched

Medicago, IDRI receive FDA approval to commence Phase 1 H5N1 vaccine trial

Low adropin levels may increase risk of metabolic disease

Physical activity effective in reducing sclerostin in premenopausal women

Special device provides evidence of how bloodstream infections begin

Continuous oral contraceptives provide earlier relief for women with dysmenorrhea

Article describes novel technique to study interactions between HIV-1 and P. falciparum

RNA-delivering nanoparticles allow rapid screening of new drug targets in mice

Inhibiting over-production of Panx1 protein can treat melanoma

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News